4//SEC Filing
New Enterprise Associates 14, L.P. 4
Accession 0001209191-20-050709
CIK 0001442836other
Filed
Sep 15, 8:00 PM ET
Accepted
Sep 16, 4:41 PM ET
Size
6.0 KB
Accession
0001209191-20-050709
Insider Transaction Report
Form 4
New Enterprise Associates 14, L.P.
10% Owner
Transactions
- Other
Common Stock
2020-09-14−2,000,000→ 5,959,520 total
Footnotes (2)
- [F1]New Enterprise Associates 14, L.P. ("NEA 14") made a pro rata distribution for no consideration of an aggregate of 2,000,000 shares of Common Stock of the Issuer to its general partner and its limited partners on September 14, 2020.
- [F2]The securities are directly held by NEA 14 and are indirectly held by NEA Partners 14, L.P. ("NEA Partners 14"), the sole general partner of NEA 14, NEA 14 GP, LTD ("NEA 14 LTD"), the sole general partner of NEA Partners 14 and each of the individual directors of NEA 14 LTD (NEA Partners 14, NEA 14 LTD and the individual directors of NEA 14 LTD (collectively, the "Directors") together, the "Indirect Reporting Persons"). The Directors of NEA 14 LTD are Forest Baskett, Anthony A. Florence, Jr., Patrick J. Kerins, Scott D. Sandell and Peter Sonsini. The Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the NEA 14 securities in which the Indirect Reporting Persons have no pecuniary interest.
Documents
Issuer
Mersana Therapeutics, Inc.
CIK 0001442836
Entity typeother
IncorporatedCayman Islands
Related Parties
1- filerCIK 0001544328
Filing Metadata
- Form type
- 4
- Filed
- Sep 15, 8:00 PM ET
- Accepted
- Sep 16, 4:41 PM ET
- Size
- 6.0 KB